← Back to Search

Bone Graft Substitute

Actifuse SHAPE vs Autograft for Spinal Cord Disease

N/A
Waitlist Available
Led By Hazem Eltahawy, MD
Research Sponsored by Wayne State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
The subject is skeletally mature (epiphyses closed)
The subject has failed conservative treatment and is a candidate for spinal fusion surgery
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 6 weeks, 6 months, 12 months, 24 months
Awards & highlights

Study Summary

This trial is testing whether a commercially available bone graft substitute works as well as bone marrow aspirate and autograft for anterior cervical corpectomy in patients with cervical spondylotic myelopathy.

Who is the study for?
This trial is for adults over 18 who need spinal fusion surgery due to cervical spondylosis and haven't improved with other treatments. They must be able to follow the study plan, attend follow-ups, and not be pregnant or planning pregnancy for a year post-surgery. Exclusions include infection, substance abuse history, involvement in another study that affects results, certain bone diseases or allergies, severe obesity, legal issues related to spine conditions, excessive surgical risk factors like heart or lung disease.Check my eligibility
What is being tested?
The trial is testing two types of bone graft substitutes in patients undergoing anterior cervical corpectomy (ACC) spinal fusion: Actifuse mixed with bone marrow aspirate versus autograft mixed with demineralized bone matrix. It aims to compare their effectiveness in achieving spinal fusion and improving clinical outcomes over a period of two years.See study design
What are the potential side effects?
Potential side effects may relate to the surgical procedure itself such as pain at the graft site, infection risks associated with surgery and anesthesia complications. Specific side effects from Actifuse SHAPE or DBX are not detailed but could include reactions at the implantation site or issues related to bone healing.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My bones have finished growing.
Select...
My back treatment didn’t work, and I need surgery to fuse my spine.
Select...
I am 18 years old or older and can legally consent.
Select...
I have not had surgery on the specific spine levels affected.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 6 weeks, 6 months, 12 months, 24 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 6 weeks, 6 months, 12 months, 24 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Fusion Rates
Secondary outcome measures
Change in Clinical Outcomes

Trial Design

2Treatment groups
Experimental Treatment
Group I: Autograft with Demineralized Bone MatrixExperimental Treatment1 Intervention
autograft mixed with demineralized bone matrix in cervical spine fusion.
Group II: Actifuse SHAPEExperimental Treatment1 Intervention
Actifuse Synthetic Bone Graft substitutes mixed with bone marrow aspirate in cervical spine fusion. Actifuse is a synthetic, porous, silicate-substituted hydroxyapatite and has shown that this maximizes a favorable bony response.

Find a Location

Who is running the clinical trial?

Wayne State UniversityLead Sponsor
307 Previous Clinical Trials
108,424 Total Patients Enrolled
Hazem Eltahawy, MDPrincipal InvestigatorWayne State University, DMC

Media Library

Actifuse SHAPE (Bone Graft Substitute) Clinical Trial Eligibility Overview. Trial Name: NCT02005081 — N/A
Actifuse SHAPE (Bone Graft Substitute) 2023 Treatment Timeline for Medical Study. Trial Name: NCT02005081 — N/A
Cervical Spondylosis Research Study Groups: Autograft with Demineralized Bone Matrix, Actifuse SHAPE
Cervical Spondylosis Clinical Trial 2023: Actifuse SHAPE Highlights & Side Effects. Trial Name: NCT02005081 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Am I eligible to participate in this investigation?

"This research endeavours to enroll 40 participants, ranging from the age of majority up to 75 years old. Participants are required to meet various criteria such as: having gone through conservative treatment and being eligible for spinal fusion surgery; not nursing or pregnant (or amenable to abstaining from pregnancy in the year after surgery); skeletally mature; and no previous surgical procedures at related levels."

Answered by AI

Are participants over the age of 80 eligible to join this medical experiment?

"This clinical trial is open to individuals who are over 18 years old, but not more than 75."

Answered by AI

Could new participants still join this experiment?

"Clinicaltrials.gov reveals that this medical trial, which was first posted on October 1st 2013 and last updated December 3rd 2013, is no longer looking for candidates. However, there are an additional 56 trials recruiting patients at the moment."

Answered by AI
~3 spots leftby Apr 2025